{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:16:07Z","timestamp":1782512167156,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T00:00:00Z","timestamp":1485216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.xphs.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T13:02:41Z","timestamp":1482238961000},"page":"1001-1007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of Sterilization Method on Protein Aggregation and Particle Formation in Polymer-Based Syringes"],"prefix":"10.1016","volume":"106","author":[{"given":"Hideaki","family":"Kiminami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2016.12.007_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/2230-973X.93004","article-title":"Prefilled syringes: an innovation in parenteral packaging","volume":"1","author":"Makwana","year":"2011","journal-title":"Int J Pharm Invest"},{"issue":"6","key":"10.1016\/j.xphs.2016.12.007_bib2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1208\/s12249-014-0167-y","article-title":"Glass delamination: a comparison of the inner surface performance of vials and pre-filled syringes","volume":"15","author":"Zhao","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"10.1016\/j.xphs.2016.12.007_bib3","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1002\/jps.21707","article-title":"Precipitation of a monoclonal antibody by soluble tungsten","volume":"98","author":"Bee","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2016.12.007_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1167\/iovs.10-6431","article-title":"Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling","volume":"52","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.xphs.2016.12.007_bib5","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/jps.21719","article-title":"Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution","volume":"98","author":"Thirumangalathu","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2016.12.007_bib6","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1002\/jps.21834","article-title":"Immunogenicity of aggregates of recombinant human growth hormone in mouse models","volume":"98","author":"Fradkin","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2016.12.007_bib7","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/jps.23945","article-title":"Functional evaluation and characterization of a newly developed silicone oil-free prefillable syringe system","volume":"103","author":"Yoshino","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2016.12.007_bib8","first-page":"47","article-title":"Development of new prefillable syringe to solve pharmaceutical problems on biological drug formulation","volume":"30","author":"Yoshino","year":"2014","journal-title":"Pharm Tech Jpn"},{"key":"10.1016\/j.xphs.2016.12.007_bib9","first-page":"10","article-title":"Using prefillable syringes for biopharmaceuticals\u2014development & challenges","volume":"55","author":"Dierick","year":"2015","journal-title":"OnDrug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2016.12.007_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jps.24184","article-title":"Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins","volume":"104","author":"Krayukhina","year":"2015","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2016.12.007_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.5731\/pdajpst.2015.01080","article-title":"Low leachable container system consisting of a polymer-based syringe with chlorinated isoprene isobutene rubber plunger stopper","volume":"69","author":"Kiminami","year":"2015","journal-title":"PDA J Pharm Sci Technol"},{"issue":"4","key":"10.1016\/j.xphs.2016.12.007_bib12","first-page":"24","article-title":"Design & evaluation of a polymer-based prefillable syringe for biopharmaceuticals with improved functionality & performance","volume":"15","author":"Bose","year":"2015","journal-title":"Drug Develop Deliv"},{"issue":"11","key":"10.1016\/j.xphs.2016.12.007_bib13","first-page":"37","article-title":"Development of the leachable pre-fillable syringe system","volume":"31","author":"Kiminami","year":"2015","journal-title":"Pharm Tech Jpn"},{"key":"10.1016\/j.xphs.2016.12.007_bib14","series-title":"Pre-filled syringes; Case in Point","first-page":"62","author":"Dierick","year":"2015"},{"issue":"7","key":"10.1016\/j.xphs.2016.12.007_bib15","first-page":"93","article-title":"Effect of pre-fillable syringe sterilization methods on biopharmaceuticals","volume":"32","author":"Nakamura","year":"2016","journal-title":"Pharm Tech Jpn"},{"key":"10.1016\/j.xphs.2016.12.007_bib16","first-page":"50","article-title":"Ready-to-use; prefillable syringes: sterilization effects on biopharmaceuticals","volume":"71","author":"Dierick","year":"2016","journal-title":"OnDrugDelivery"},{"key":"10.1016\/j.xphs.2016.12.007_bib17","series-title":"Guidance for Industry. Immunogenicity Assessment for Therapeutic Protein Products","year":"2014"},{"key":"10.1016\/j.xphs.2016.12.007_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijpharm.2015.02.020","article-title":"Assessment of the effects of sterilization methods on protein drug stability by elucidating decomposition mechanism and material analysis","volume":"484","author":"Nakamura","year":"2015","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2016.12.007_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jps.23401","article-title":"Effects of solution conditions on methionine oxidation in albinterferon alfa-2b and the role of oxidation in its conformation and aggregation","volume":"102","author":"Chou","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2016.12.007_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejpb.2013.03.015","article-title":"Influence of methionine oxidation on the aggregation of recombinant human growth hormone","volume":"85","author":"Mulinacci","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2016.12.007_bib21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1021\/acs.molpharmaceut.5b00944","article-title":"Site-specific hydrolysis reaction C-terminal of methionine in Met-His during metal-catalyzed oxidation of IgG-1","volume":"13","author":"Mozziconacci","year":"2016","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2016.12.007_bib22","first-page":"211","article-title":"The oxidation of methionine-54 of epoetinum alfa does not affect molecular structure or stability, but does decrease biological activity","volume":"62","author":"Labrenz","year":"2008","journal-title":"PDA J Pharm Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2016.12.007_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5731\/pdajpst.2015.01009","article-title":"A\u00a0strategy for the prevention of protein oxidation by drug product in polymer-based syringes","volume":"69","author":"Nakamura","year":"2015","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.xphs.2016.12.007_bib24","article-title":"Selecting materials for medical products","author":"Sherwin","year":"2012"},{"key":"10.1016\/j.xphs.2016.12.007_bib25","series-title":"Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products Guidance for Industry DRAFT GUIDANCE","author":"Susan","year":"2016"},{"issue":"12","key":"10.1016\/j.xphs.2016.12.007_bib26","first-page":"34","article-title":"A\u00a0risk-based approach to immunogenicity concerns of therapeutic protein products, part 2: considering host-specific and product specific factors impacting immunogenicity","volume":"17","author":"Rosenberg","year":"2004","journal-title":"Biopharm Int"},{"issue":"3","key":"10.1016\/j.xphs.2016.12.007_bib27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-3549(15)00180-X","article-title":"Subvisible particle content, formulation, and dose of an erythropoietin peptide mimetic product are associated with severe adverse postmarketing events","volume":"105","author":"Kotarek","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2016.12.007_bib28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/jps.24156","article-title":"Calculating the mass of subvisible protein particles with improved accuracy using Microflow Imaging data","volume":"104","author":"Kalonia","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2016.12.007_bib29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s11095-014-1541-x","article-title":"Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics","volume":"32","author":"Ahmadi","year":"2015","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2016.12.007_bib30","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.xphs.2016.02.031","article-title":"Mouse models for assessing protein immunogenicity: lessons and challenges","volume":"105","author":"Jiskoot","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2016.12.007_bib31","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1007\/s11095-011-0621-4","article-title":"Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity","volume":"29","author":"Seidl","year":"2012","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.xphs.2016.12.007_bib32","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/jps.23244","article-title":"Managing uncertainty: a perspective on risk pertaining to product quality attributes as they bear on immunogenicity of therapeutic proteins","volume":"101","author":"Rosenberg","year":"2012","journal-title":"J\u00a0Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916418964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916418964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T05:19:49Z","timestamp":1666415989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916418964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0022354916418964"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2016.12.007","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Sterilization Method on Protein Aggregation and Particle Formation in Polymer-Based Syringes","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association?\u00ae\u0090.","name":"copyright","label":"Copyright"}]}}